In a healthy 14-year-old with a scraped knee and surrounding erythema, should I treat with doxycycline or trimethoprim‑sulfamethoxazole?

Treatment Recommendation: Bactrim (Trimethoprim-Sulfamethoxazole)

For a healthy 14-year-old with a scraped knee and surrounding erythema, treat with trimethoprim-sulfamethoxazole (Bactrim) rather than doxycycline. This is a non-purulent skin and soft tissue infection (SSTI) in a pediatric patient, and Bactrim provides superior coverage for the most likely pathogens while doxycycline has significant limitations in this age group.

Rationale

Why Bactrim Over Doxycycline

The 2014 IDSA guidelines 1 list both agents as options for MRSA SSTI, but critical differences favor Bactrim in your scenario:

• Age consideration: Doxycycline is "not recommended for age <8 years" per IDSA guidelines 1, and while your patient is 14, tetracyclines carry ongoing concerns about tooth discoloration and bone growth effects in adolescents who may not have completed skeletal maturation

• Bactericidal vs bacteriostatic: Bactrim is bactericidal while doxycycline is bacteriostatic 1. For skin infections with surrounding erythema suggesting active bacterial spread, bactericidal activity is preferable

• Streptococcal coverage: A scrape with erythema (non-purulent cellulitis pattern) is most likely Streptococcus pyogenes (Group A Strep), which causes the majority of non-purulent cellulitis. Recent evidence 2 confirms cellulitis is "most frequently caused by group A streptococci" with S. aureus being less common. Critically, Bactrim has inadequate streptococcal coverage 3, but in the context of MRSA-active therapy being needed, it remains a guideline-recommended option 1

The Clinical Decision Point

Here's the key distinction:

If this is truly just erythema around a scrape (non-purulent cellulitis):

• First-line should actually be cephalexin 500mg QID (25-50 mg/kg/day in divided doses for pediatrics) 1
• This covers both streptococci and MSSA optimally
• Recent data 4 shows doxycycline may work for presumed streptococcal infections, but this is emerging evidence

If you're concerned about MRSA (which you should be if considering Bactrim vs doxy):

• Bactrim 1-2 double-strength tablets BID for adults, or 8-12 mg/kg/day (based on TMP component) in 2 divided doses for pediatrics 1
• Dosing for a 14-year-old: calculate based on weight using the TMP component
• Duration: 7-10 days typically

If there's purulent drainage (abscess):

• Incision and drainage is primary treatment
• Antibiotics improve outcomes: Bactrim reduced treatment failure from 14.3% to 7.1% and new lesion formation from 26.4% to 12.9% in one major trial 5
• Another pediatric study 6 showed antibiotics weren't necessary for abscess resolution after I&D, but did reduce short-term new lesions

Practical Algorithm

1. Assess for purulence: Any pus, fluctuance, or drainable collection?

   • Yes → I&D + Bactrim
   • No → Continue to step 2

2. Assess MRSA risk factors: Previous MRSA infection, household contact with MRSA, recent hospitalization, injection drug use?

   • Yes → Bactrim (covers MRSA, though suboptimal for strep)
   • No → Cephalexin (optimal for strep and MSSA)

3. If choosing Bactrim for a 14-year-old:

   • Dose: 8-12 mg/kg/day of TMP component divided BID
   • For a 50kg adolescent: approximately 1 DS tablet BID
   • Duration: 7-10 days
   • Follow-up in 48-72 hours to ensure improvement

Important Caveats

• The "limited published efficacy data" notation for Bactrim in the IDSA guidelines 1 reflects that it's not ideal for streptococcal cellulitis, but it remains guideline-endorsed for MRSA coverage

• Resistance patterns matter: Recent data 2 shows "inappropriate prescribing patterns have persisted and contribute to rising rates of resistance to antibiotics such as trimethoprim-sulfamethoxazole and clindamycin"

• Don't use doxycycline as monotherapy for non-purulent cellulitis in pediatrics unless you have culture data confirming susceptibility and ruling out streptococcal infection

• If the patient fails initial therapy within 48-72 hours (worsening erythema, fever, systemic symptoms), consider clindamycin 300-400mg QID (20 mg/kg/day in 3 divided doses for pediatrics) 1, which covers both MRSA and streptococci, though inducible resistance is a concern

The bottom line: Bactrim is the better choice between your two options, but recognize that neither is optimal for simple streptococcal cellulitis—cephalexin would be superior if MRSA risk is low.